| Year |
Citation |
Score |
| 2023 |
Kalathil AA, Guin S, Ashokan A, Basu U, Surnar B, Delma KS, Lima LM, Kryvenko ON, Dhar S. Correction to "New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance". Acs Central Science. 9: 1705. PMID 37637725 DOI: 10.1021/acscentsci.3c00920 |
0.682 |
|
| 2023 |
Kalathil AA, Guin S, Ashokan A, Basu U, Surnar B, Delma KS, Lima LM, Kryvenko ON, Dhar S. New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance. Acs Central Science. 9: 1297-1312. PMID 37521786 DOI: 10.1021/acscentsci.3c00286 |
0.701 |
|
| 2023 |
Zhang X, Sarkar S, Ashokan A, Surnar B, Kolishetti N, Dhar S. All-in-One Pyruvate Dehydrogenase Kinase Inhibitor for Tracking, Targeting, and Enhanced Efficacy. Bioconjugate Chemistry. 34: 1122-1129. PMID 37279374 DOI: 10.1021/acs.bioconjchem.3c00152 |
0.801 |
|
| 2023 |
Banik B, Ashokan A, Choi JH, Surnar B, Dhar S. Platin- containing nanoparticles: a recipe for the delivery of curcumin-cisplatin combination chemotherapeutics to mitochondria. Dalton Transactions (Cambridge, England : 2003). PMID 36723189 DOI: 10.1039/d2dt03149c |
0.791 |
|
| 2022 |
Shah AS, Surnar B, Kolishetti N, Dhar S. Intersection of Inorganic Chemistry and Nanotechnology for the Creation of New Cancer Therapies. Accounts of Materials Research. 3: 283-296. PMID 37091880 DOI: 10.1021/accountsmr.1c00178 |
0.702 |
|
| 2022 |
Ciciriello AJ, Surnar B, Medy GD, Su X, Dhar S, Dumont CM. Biomaterial-targeted precision nanoparticle delivery to the injured spinal cord. Acta Biomaterialia. PMID 36087868 DOI: 10.1016/j.actbio.2022.08.077 |
0.636 |
|
| 2022 |
Hamdan S, Surnar B, Kafkoutsou AL, Magurno L, Deo SK, Jayaweera DT, Dhar S, Daunert S. Transformation of Amphiphilic Antiviral Drugs into New Dimensional Nanovesicles Structures. Acs Omega. 7: 21359-21369. PMID 35785276 DOI: 10.1021/acsomega.1c05758 |
0.604 |
|
| 2021 |
Costoya J, Surnar B, Kalathil AA, Kolishetti N, Dhar S. Controlled release nanoplatforms for three commonly used chemotherapeutics. Molecular Aspects of Medicine. 101043. PMID 34920863 DOI: 10.1016/j.mam.2021.101043 |
0.768 |
|
| 2021 |
Shah A, Lopez I, Surnar B, Sarkar S, Duthely LM, Pillai A, Salguero TT, Dhar S. Turning the Tide for Academic Women in STEM: A Postpandemic Vision for Supporting Female Scientists. Acs Nano. PMID 34850631 DOI: 10.1021/acsnano.1c09686 |
0.671 |
|
| 2021 |
Olagunju MO, Zahran EM, Zeynaloo E, Shukla D, Cohn JL, Surnar B, Dhar S, Bachas LG, Knecht MR. Design of Pd-Decorated SrTiO/BiOBr Heterojunction Materials for Enhanced Visible-Light-Based Photocatalytic Reactivity. Langmuir : the Acs Journal of Surfaces and Colloids. PMID 34608800 DOI: 10.1021/acs.langmuir.1c01537 |
0.551 |
|
| 2021 |
Surnar B, Shah AS, Guin S, Kolishetti N, Fornoni A, Dhar S. Blending of Designer Synthetic Polymers to a Dual Targeted Nanoformulation for SARS-CoV-2 Associated Kidney Damage. Biomacromolecules. PMID 34492195 DOI: 10.1021/acs.biomac.1c00799 |
0.751 |
|
| 2021 |
Surnar B, Shah AS, Park M, Kalathil AA, Kamran MZ, Ramirez Jaime R, Toborek M, Nair M, Kolishetti N, Dhar S. Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress. Acs Nano. PMID 34355558 DOI: 10.1021/acsnano.0c09553 |
0.75 |
|
| 2020 |
Surnar B, Kamran MZ, Shah AS, Dhar S. Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19. Acs Pharmacology & Translational Science. 3: 1371-1380. PMID 33330844 DOI: 10.1021/acsptsci.0c00179 |
0.65 |
|
| 2020 |
Kolb D, Kolishetti N, Surnar B, Sarkar S, Guin S, Shah AS, Dhar S. Metabolic Modulation of the Tumor Microenvironment Leads to Multiple Checkpoint Inhibition and Immune Cell Infiltration. Acs Nano. PMID 32706241 DOI: 10.1021/Acsnano.9B10037 |
0.764 |
|
| 2019 |
Banik B, Surnar B, Askins B, Banerjee M, Dhar S. Dual Targeted Synthetic Nanoparticle for Cardiovascular Diseases. Acs Applied Materials & Interfaces. PMID 31886643 DOI: 10.1021/Acsami.9B19036 |
0.769 |
|
| 2019 |
Surnar B, Kamran MZ, Shah AS, Basu U, Kolishetti N, Deo S, Jayaweera DT, Daunert S, Dhar S. Orally Administrable Therapeutic Synthetic Nanoparticle for Zika Virus. Acs Nano. PMID 31603314 DOI: 10.1021/Acsnano.9B02807 |
0.783 |
|
| 2019 |
Velichkovska M, Surnar B, Nair M, Dhar S, Toborek M. Targeted Mitochondrial COQ Delivery Attenuates Antiretroviral-Drug-Induced Senescence of Neural Progenitor Cells. Molecular Pharmaceutics. 16: 724-736. PMID 30592424 DOI: 10.1021/Acs.Molpharmaceut.8B01014 |
0.657 |
|
| 2018 |
Surnar B, Basu U, Banik B, Ahmad A, Marples B, Kolishetti N, Dhar S. Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection. Proceedings of the National Academy of Sciences of the United States of America. PMID 30530697 DOI: 10.1073/Pnas.1816429115 |
0.752 |
|
| 2018 |
Pathak RK, Basu U, Ahmad A, Sarkar S, Kumar A, Surnar B, Ansari S, Wilczek K, Ivan ME, Marples B, Kolishetti N, Dhar S. A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation. Biomaterials. 187: 117-129. PMID 30336364 DOI: 10.1016/J.Biomaterials.2018.08.062 |
0.786 |
|
| 2018 |
Surnar B, Kolishetti N, Basu U, Ahmad A, Goka E, Marples B, Kolb D, Lippman M, Dhar S. Reduction of cisplatin induced ototoxicity without compromising its antitumor activity. Biochemistry. PMID 30281285 DOI: 10.1021/Acs.Biochem.8B00712 |
0.785 |
|
| 2016 |
Surnar B, Jayakannan M. Triple Block Nanocarrier Platform for Synergistic Cancer Therapy of Antagonistic Drugs. Biomacromolecules. 17: 4075-4085. PMID 27936725 DOI: 10.1021/acs.biomac.6b01608 |
0.302 |
|
| 2016 |
Kulkarni B, Surnar B, Jayakannan M. Dual Functional Nanocarrier for Cellular Imaging and Drug Delivery in Cancer Cells Based on π-Conjugated Core and Biodegradable Polymer Arms. Biomacromolecules. 17: 1004-16. PMID 26842888 DOI: 10.1021/acs.biomac.5b01654 |
0.301 |
|
| Show low-probability matches. |